- Home
- CADL vs NNOX Comparison
CADL vs NNOX Comparison
Compare CADL & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- NNOX
- Stock Information
- Founded
- CADL 1999
- NNOX 2011
- Country
- CADL United States
- NNOX Israel
- Employees
- CADL N/A
- NNOX N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- CADL Health Care
- NNOX Health Care
- Exchange
- CADL Nasdaq
- NNOX Nasdaq
- Market Cap
- CADL 278.6M
- NNOX 305.7M
- IPO Year
- CADL 2021
- NNOX 2020
- Fundamental
- Price
- CADL $5.95
- NNOX $4.06
- Analyst Decision
- CADL Strong Buy
- NNOX Strong Buy
- Analyst Count
- CADL 5
- NNOX 2
- Target Price
- CADL $21.40
- NNOX $8.50
- AVG Volume (30 Days)
- CADL 627.9K
- NNOX 1.4M
- Earning Date
- CADL 08-14-2025
- NNOX 08-12-2025
- Dividend Yield
- CADL N/A
- NNOX N/A
- EPS Growth
- CADL N/A
- NNOX N/A
- EPS
- CADL N/A
- NNOX N/A
- Revenue
- CADL N/A
- NNOX $11,886,000.00
- Revenue This Year
- CADL N/A
- NNOX $23.81
- Revenue Next Year
- CADL N/A
- NNOX $149.38
- P/E Ratio
- CADL N/A
- NNOX N/A
- Revenue Growth
- CADL N/A
- NNOX 17.36
- 52 Week Low
- CADL $3.79
- NNOX $3.75
- 52 Week High
- CADL $14.60
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- CADL 47.68
- NNOX 32.71
- Support Level
- CADL $5.45
- NNOX $3.83
- Resistance Level
- CADL $6.16
- NNOX $4.56
- Average True Range (ATR)
- CADL 0.32
- NNOX 0.22
- MACD
- CADL -0.07
- NNOX -0.06
- Stochastic Oscillator
- CADL 48.54
- NNOX 20.54
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.